KLYV THERAPEUTICS AS

Signals

1 flags

• ◆ Nylig endring 2026-04-20 Aksjekapital registrert 2026-04-20.

KLYV THERAPEUTICS AS is registered as a limited company in Oslo, Oslo with organisation number 832316032. The business is classified under research and experimental development on natural sciences and engineering (NACE 72.100). The company was incorporated in 2023. Registered share capital is NOK 122,000, divided into 121816 shares. The company's stated purpose is: “Utvikle og investere i legemidler, legemiddelkandidater, hjelpemidler, verktøy og metoder for pasientbehandling og persontilpasset medisin.”. The most recent filed accounts, for the 2024 financial year, show NOK 935,000 in revenue and NOK 161,000 in operating profit.

Key figures · 2024

Revenue

NOK 935,000

Operating profit

NOK 161,000

Equity

NOK 718,000

Est. value

NOK 1.2m

Financial health · 2024

Liquidity

4.31

Very good

Current assets ÷ current liabilities

Profitability

–

Not available

Return on total assets

Solidity

76.8%

Very good

Equity as a share of total capital

Who owns KLYV THERAPEUTICS AS?

SPRINGHEART HOLDING AS

77.5%

KLYV THERAPEUTICS AS

NOK 935,000 rev. · NOK 161,000 profit

KLYV THERAPEUTICS AS has 5 registered shareholders:

• SPRINGHEART HOLDING AS 77.5%
• TAILORMADE INVEST AS 19.8%
• PRECO AS 1.4%
• BERET LUISE SUNDET 0.6%
• ALEFA AS 0.6%

All shareholders and roles →

Frequently asked questions about KLYV THERAPEUTICS AS

Who owns KLYV THERAPEUTICS AS?

SPRINGHEART HOLDING AS is the largest registered owner, with 77.5%.

What is the revenue of KLYV THERAPEUTICS AS?

KLYV THERAPEUTICS AS had revenue of NOK 935,000 in 2024.

Who is the general manager of KLYV THERAPEUTICS AS?

Maria Vistnes is registered as general manager of KLYV THERAPEUTICS AS.

Where is KLYV THERAPEUTICS AS based?

KLYV THERAPEUTICS AS has its business address in Oslo.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.